Description
Gram-Positive Bacteria:
Enterococcus, Listeria monocytogenes, Staphylococcus aureus, Streptococcus agalactiae, Streptococcus pneumonia, Streptococcus pyogenes
Gram-Negative Bacteria:
Acinetobacter baumannii, Haemophilius influenza, Neisseria meningitides, Pseudomonas aeruginosa, Enterobacter cloacae complex, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumonia, Proteus, Serratia marcescens
Yeast:
Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis Anti-microbial Resistance Genes:
mecA ? methicillin resistance vanA/B ? vacomycin resistance KPC ? carbapenem resistance
Sample Type: Serum, Plasma
[0.2 mL of positive blood culture]
Tests Included:
This panel comprises a comprehensive set of tests using advanced molecular methods to identify various bacterial and fungal pathogens in blood cultures.
Sample Required:
Blood sample from the patient.
Test Time:
Results might be available within 24-48 hours depending on the specific pathogens identified.
Test Range Values:
The test identifies the presence of specific pathogens and may provide susceptibility information for antibiotics.
What is the test?
The BCID Panel uses advanced techniques to detect a wide range of bacterial and fungal pathogens in blood cultures rapidly and accurately.
Test Procedure:
Blood cultures are taken from the patient, which are then subjected to molecular testing methods to identify specific pathogens.
When to take the test:
This test is ordered when there’s suspicion of bloodstream infection or sepsis to quickly identify the causative agent for prompt and targeted treatment.
Who should take the test:
Patients showing signs of sepsis or suspected bloodstream infections, especially those who are critically ill, might require this test.
Precautions for exceptional cases (if any):
Timely collection of blood samples before antibiotic administration is crucial for accurate results.
Frequently Asked Questions (FAQs) for Blood Culture Identification (BCID) Panel:
Q1: Why is the BCID Panel important?
A: It provides rapid identification of pathogens causing bloodstream infections, aiding in prompt administration of appropriate antibiotics.
Q2: What pathogens can the panel identify?
A: It can identify a wide range of bacteria and fungi commonly associated with bloodstream infections.
Q3: Can this test determine antibiotic resistance?
A: Some versions of the panel might provide information about certain antibiotic resistance markers.
Q4: Is this test always reliable?
A: False positives or negatives might occur, and clinical correlation is essential for accurate interpretation.
Q5: How does this test differ from traditional culture methods?
A: It provides faster results and broader pathogen coverage compared to traditional culture techniques, enabling quicker initiation of targeted treatment.
*Please note that specific testing protocols and guidelines may vary based on the latest recommendations from health authorities and regulatory agencies. It is essential to consult healthcare professionals and follow local testing guidelines for accurate and appropriate testing.
